Uridine release during aminopyridine-induced epilepsy

Neurobiology of Disease

Volumn 16, Issue 3, 2004, Pages 490-499

  Slezia A ^a   Kekesi A K ^a   Szikra, T ^a   Papp, A M ^a   Nagy, K ^b   Szente, M ^b   Magloczky Zs ^c   Freund, T F ^c   Juhasz G ^a  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

3 aminopyridine; 3 AP; 4 aminopyridine; 4 AP; ABC; ACSF; Adenosine; artificial cerebrospinal fluid; avidin biotin peroxidase complex; CA1; CA2; EEG; Epilepsy; hippocampal Cornu Ammonis 1; hippocampal Cornu Ammonis 2; Hippocampus; Inosine; Microdialysis; Rat; Uridine

Indexed keywords

ADENOSINE; AMINO ACID; AMINOPYRIDINE; CALRETININ; GLUTAMIC ACID; INOSINE; NUCLEOSIDE; PARVALBUMIN; URIDINE;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTROCORTICOGRAPHY; EPILEPSY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTERNEURON; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; SILVER IMPREGNATION;

AMINO ACIDS; AMINOPYRIDINES; ANIMALS; ELECTROENCEPHALOGRAPHY; EPILEPSY; EXTRACELLULAR SPACE; HIPPOCAMPUS; INJECTIONS, INTRAVENOUS; MALE; MICRODIALYSIS; NUCLEOSIDES; RATS; RATS, SPRAGUE-DAWLEY; URIDINE;

EID: 3242734169     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2004.02.011     Document Type: Article

References (71)

1. Abbracchio M.P., Cattabeni F. Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases. Ann. N. Y. Acad. Sci. 890:1999;79-92
2. Abbracchio M.P., Ceruti S., Barbieri D., Franceschi C., Malorni W., Biondo L., Burnstock G., Cattabeni F. A novel action for adenosine: apoptosis of astroglial cells in rat brain primary cultures. Biochem. Biophys. Res. Commun. 213:1995;908-915
3. Agnati L.F., Fuxe K., Eneroth P., Zini I., Harfstrand A., Grimaldi R., Zoli M. Intravenous uridine treatment antagonizes hypoglycaemia-induced reduction in brain somatostatin-like immunoreactivity. Acta Physiol. Scand. 126:1986;525-531
4. Baimbridge K.G., Miller J.J. Immunohistochemical localization of calcium-binding protein in the cerebellum, hippocampal formation and olfactory bulb of the rat. Brain Res. 245:1982;223-229
5. Baimbridge K.G., Miller J.J., Parkes C.O. Calcium-binding protein distribution in the rat brain. Brain Res. 239:1982;519-525
6. Baldwin S.A., Mackey J.R., Cass C.E., Young J.D. Nucleoside transporters: molecular biology and implications for therapeutic development. Mol. Med. Today. 5:1999;216-224
7. Bazzett T.J., Becker J.B., Falik R.C., Albin R.L. Chronic intrastriatal quinolinic acid produces reversible changes in perikaryal calbindin and parvalbumin immunoreactivity. Neuroscience. 60:1994;837-841
8. Beal M.F. Mechanisms of excitotoxicity in neurologic diseases. FASEB J. 6:1992;3338-3344
9. Berman R.F., Fredholm B.B., Aden U., O'Connor W.T. Evidence for increased dorsal hippocampal adenosine release and metabolism during pharmacologically induced seizures in rats. Brain Res. 872:2000;44-53
10. Cass C.E., Young J.D., Baldwin S.A., Cabrita M.A., Graham K.A., Griffiths M., Jennings L.L., Mackey J.R., Ng A.M., Ritzel M.W., Vickers M.F., Yao S.Y. Nucleoside transporters of mammalian cells. Pharm. Biotechnol. 12:1999;313-352
11. Chin J.H. Adenosine receptors in brain: neuromodulation and role in epilepsy. Ann. Neurol. 26:1989;695-698
12. Choi D.W. Ionic dependence of glutamate neurotoxicity. J. Neurosci. 7:1987;369-379
13. Choi D.W. Excitotoxic cell death. J. Neurobiol. 23:1992;1261-1276
14. Connolly G.P, Duley J.A. Uridine and its nucleotides: biological actions, therapeutic potentials. Trends Pharmacol. Sci. 20:1999;218-225
15. Cunha R.A. Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem. Int. 38:2001;107-125
16. de Mendonca A., Ribeiro J.A. Adenosine inhibits the NMDA receptor-mediated excitatory postsynaptic potential in the hippocampus. Brain Res. 606:1993;351-356
17. de Mendonca A., Sebastiao A.M., Ribeiro J.A. Adenosine: does it have a neuroprotective role after all? Brain Res. Rev. 33:2000;258-274
18. Dobolyi A., Reichart A., Szikra T., Szilágyi N., Kékesi A.K., Karancsi T., Slégel P., Palkovits M., Juhász G. Analysis of purine and pyrimidine bases, nucleosides and deoxynucleosides in brain microsamples (microdialysates and micropunches) and cerebrospinal fluid. Neurochem. Int. 32:1998;247-256
19. Dobolyi A., Szikra T., Kékesi A.K., Kovács Z., Juhász G. Uridine is released by depolarization and inhibits unit activity in the rat hippocampus. NeuroReport. 10:1999;3049-3053
20. Dobolyi A., Reichart A., Szikra T., Nyitrai G., Kékesi K.A., Juhász G. Sustained depolarisation induces changes in the extracellular concentrations of purine and pyrimidine nucleosides in the rat thalamus. Neurochem. Int. 37:2000;71-79
21. Dolphin A.C., Archer E.R. An adenosine agonist inhibits and a cyclic AMP analogue enhances the release of glutamate but not GABA from slices of rat dentate gyrus. Neurosci. Lett. 43:1983;49-54
22. Dolphin A.C., Forda S.R., Scott R.H. Calcium-dependent currents in cultured rat dorsal root ganglion neurons are inhibited by an adenosine analogue. J. Physiol. (London). 373:1986;47-61
23. Freund T.F., Maglóczky Z. Early degeneration of calretinin-containing neurons in the rat hippocampus after ischemia. Neuroscience. 56:1993;581-596
24. Fredholm B.B. Adenosine and neuroprotection. Green A.R., Cross A.R. Neuroprotective Agents and Neuroprotection. vol. 40:1997;259-280 Academic Press, London
25. Gallyas F., Wolff J.R., Bottcher H., Zaborszky L. A reliable and sensitive method to localize terminal degeneration and lysosomes in the central nervous system. Stain Technol. 55:1980;299-306
26. Guarneri P., Guarneri R., Mocciaro C., Piccoli F. Interaction of uridine with GABA binding sites in cerebellar membranes of the rat. Neurochem. Res. 8:1983;1537-1545
27. Guarneri P., Guarneri R., La Bella V., Piccoli F. Interaction between uridine and GABA-mediated inhibitory transmission: studies in vivo and in vitro. Epilepsia. 26:1985;666-671
28. Gulyás A.I., Hájos N., Freund T.F. Interneurons containing calretinin are specialized to control other interneurons in the rat hippocampus. J. Neurosci. 16:1996;3397-3411
29. Inoue S., Honda K., Komoda Y., Uchizono K., Ueno R., Hayaishi O. Differential sleep-promoting effects of five sleep substances nocturnally infused in unrestrained rats. Proc. Natl. Acad. Sci. U. S. A. 81:1984;6240-6244
30. Inoue S., Honda K., Komoda Y., Uchizono K., Ueno R., Hayaishi O. Little sleep-promoting effect of three sleep substances diurnally infused in unrestrained rats. Neurosci. Lett. 49:1984;207-211
31. Inoue S., Kimura-Takeuchi M., Honda K. Co-circulating sleep substances interactingly modulate sleep and wakefulness in rats. Endocrinol. Exp. 24:1990;69-76
32. Inoue S., Honda K., Komoda Y. Sleep as neuronal detoxification and restitution. Behav. Brain Res. 69:1995;91-96
33. 3 receptors: novel ligand and paradoxal effects. TIPS. 19:1998;184-190
34. Johansen F.F., Tonder N., Zimmer J., Baimbridge K.G., Diemer N.H. Short-term changes of parvalbumin and calbindin immunoreactivity in the rat hippocampus following cerebral ischemia. Neurosci. Lett. 120:1990;171-174
35. Juhász G., Tarcali J., Pungor K., Pungor E. Electrochemical calibration of in vivo brain dialysis samples. J. Neurosci. Methods. 29:1989;131-137
36. 2+ ion fluxes in rat brain homogenates. NeuroReport. 10:1999;1577-1582
37. Kimura T., Ho I.K., Yamamoto I. Uridine receptor: discovery and its involvement in sleep mechanism. Sleep. 24:2001;251-260
38. Klitgaard H., Knutsen L.J., Thomsen C. Contrasting effects of adenosine A1 and A2 receptor ligands in different chemoconvulsive rodent models. Eur. J. Pharmacol. 242:1993;221-228
39. Lancelot E., Beal M.F. Glutamate toxicity in chronic neurodegenerative disease. Prog. Brain Res. 116:1998;331-347
40. Lara D.R., Schmidt A.P., Frizzo M.E., Burgos J.S., Ramirez G., Souza D.O. Effect of orally administered guanosine on seizures and death induced by glutamatergic agents. Brain Res. 912:2001;176-180
41. Lewin E., Bleck V. Electroshock seizures in mice: effect on brain adenosine and its metabolites. Epilepsia. 22:1981;577-581
42. Li X-G., Somogyi P., Ylinen A., Buzsáki G. The hippocampal CA3 network: an in vivo intracellular labeling study. J. Comp. Neurol. 339:1994;181-208
43. 2a adenosine receptors. Life Sci. 68:2001;1343-1350
44. 1 receptor inhibition. Neuroscience. 112:2002;319-329
45. Maglóczky Z., Freund T.F. Selective neuronal death in the contralateral hippocampus following unilateral kainate injections into the CA3 subfield. Neuroscience. 56:1993;317-335
46. Maglóczky Z., Freund T.F. Delayed cell death in the contralateral hippocampus following kainate injection into the CA3 subfield. Neuroscience. 66:1995;847-860
47. Medina-Ceja L., Moralles-Villagran A., Tapia R. Action of 4-aminopyridine on extracellular amino acids in hippocampus and entorhinal cortex: a dual microdialysis and electroencephalographic study in awake rats. Brain Res. Bull. 53:2000;255-262
48. Meldrum B.S. Excitatory amino acid receptors and disease. Curr. Opin. Neurol. Neurosurg. 5:1992;508-513
49. Meldrum B., Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11:1990;379-387
50. Mody I., Otis T.S., Staley K.J., Kohr G. The balance between excitation and inhibition in dentate granule cells and its role in epilepsy. Epilepsy Res. 9:1992;331-339. (Suppl.)
51. Myers C.S., Fisher H., Wagner G.C. Uridine reduces rotation induced by L-dopa and methamphetamine in 6-OHDA-treated rats. Pharmacol. Biochem. Behav. 52:1995;749-753
52. Nino A., Munoz-Caro C. Theoretical analysis of the molecular determinants responsible for the K(+) channel blocking by aminopyridines. Biophys. Chem. 91:2001;49-60
53. Page T., Yu A., Fontanesi J., Nyhan W.L. Developmental disorder associated with increased cellular nucleotidase activity. Proc. Natl. Acad. Sci. U. S. A. 94:1997;11601-11606
54. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1982;Academic Press, Sidney
55. Phillis J.W., Smith-Barbour M., O'Regan M.H., Perkins L.M. Amino acid and purine release in rat brain following temporary middle cerebral artery occlusion. Neurochem. Res. 19:1994;1125-1130
56. Pena F., Tapia R. Relationships among seizures, extracellular amino acid changes, and neurodegeneration induced by 4-aminopyridine in rat hippocampus: a microdialysis and electroencephalographic study. J. Neurochem. 72:1999;2006-2014
57. Pollard H., Charriaut-Marlangue C., Cantagrel S., Represa A., Robain O., Moreau J., Ben-Ari Y. Kainate-induced apoptotic cell death in hippocampal neurons. Neuroscience. 63:1994;7-18
58. Resibois A., Rogers J.H. Calretinin in rat brain: an immunohistochemical study. Neuroscience. 46:1992;101-134
59. Ribeiro J.A. Adenosine A2A receptor interactions with receptors for other neurotransmitters and neuromodulators. Eur. J. Pharmacol. 375:1999;101-113
60. Roberts C.A. Anticonvulsant effects of uridine: comparative analysis of metrazol and penicillin induced foci. Brain Res. 55:1973;291-308
61. Roberts C.A., Kreisman N.R., Waltman M. Uridine anticonvulsant effects: selective control of nucleoside incorporation in experimental epilepsy. Epilepsia. 15:1974;479-500
62. Rogers J.H., Resibois A. Calretinin and calbindin-D28K in rat brain: patterns of partial co-localization. Neuroscience. 51:1992;843-865
63. Rudolphi K.A., Schubert P., Parkinson F.E., Fredholm B.B. Neuroprotective role of adenosine in cerebral ischaemia. Trends Pharmacol. Sci. 13:1992;439-445
64. Schmidt A.P., Lara D.R., de Faria Maraschin J., da Silveira Perla A., Onofre Souza D. Guanosine and GMP prevent seizures induced by quinolinic acid in mice. Brain Res. 864:2000;40-43
65. Szente M., Baranyi A. Mechanisms of aminopyridine-induced ictal seizure activity in the cat neocortex. Brain Res. 423:1987;368-373
66. Szente M., Boda B. Cellular mechanism of secondary epileptogenesis. Brain Res. 648:1994;203-214
67. Szente M., Pongrácz F. Aminopyridine-induced seizure activity. EEG Clin. Neurophysiol. 46:1979;605-608
68. Tortosa A., Ferrer I. Parvalbumin immunoreactivity in the hippocampus of the gerbil after transient forebrain ischaemia: a qualitative and quantitative sequential study. Neuroscience. 55:1993;33-43
69. 3 receptor agonist and cerebral ischemia: neuronal and glial effects. Eur. J. Pharmacol. 367:1999;157-163
70. Wittner L., Maglóczky Z., Borhegyi Z., Halász P., Szabó Z., Freund T.F. Preservation of perisomatic inhibitory input of granule cells in the epileptic human dentate gyrus. Neuroscience. 108:2001;587-600
71. Zhang J., Niu X. Changes of monoamines, purines and amino acids in rat striatum as measured by intercerebral microdialysis during ischemia/reperfusion. Chin. Med. Sci. J. 9:1994;225-229